Endo USA, Inc. Ireland

The 90-second commercial builds on the "Bent Carrot" campaign, launched in 2021, with creative that highlights a couple's journey from diagnosis to treatment.It spotlights the copay program designed to increase patient access and support a potential $0 out-of-pocket pathway for commercially insured patients.XIAFLEX is the only FDA-approved treatment for Peyronie's disease.View original content:https://www.prnewswire.co.uk/news-releases/prime-time-a-branded-peyronies-disease-commercial-for-xiaflex-collagenase-clostridium-histolyticum-302527212.html